206 results on '"Chang, Tse Wen"'
Search Results
2. Site-specific Conjugation of 6 DOTA Chelators to a CA19-9-targeting scFv-Fc Antibody for Imaging and Therapy
3. Abstract LB209: An ADC composed of daratumumab and lenalidomide is extremely powerful in killing multiple myeloma cells
4. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria
5. Skewed Exposure to Environmental Antigens Complements Hygiene Hypothesis in Explaining the Rise of Allergy
6. Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response
7. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody
8. The pharmacological mechanisms of omalizumab in patients with very high IgE levels—Clues from studies on atopic dermatitis
9. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors
10. Crawling Movements of Lymphocytes on and beneath Fibroblasts in Culture
11. Regulation of T-Cell Function by Antibodies: Enhancement of the Response of Human T-Cell Clones to Hepatitis B Surface Antigen by Antigen-Specific Monoclonal Antibodies
12. Another Discontinuous Epitope on Glycoprotein gp120 that is Important in Human Immunodeficiency Virus Type 1 Neutralization is Identified by a Monoclonal Antibody
13. Use of Monoclonal Antibodies as Sensitive and Specific Probes for Biologically Active Human γ -interferon
14. Does OKT3 Monoclonal Antibody React with an Antigen-Recognition Structure on Human T Cells?
15. Changing patterns of antigen exposure and their impact on the prevalence of allergy
16. The IgE gene in primates exhibits extraordinary evolutionary diversity
17. Alleles and isoforms of human membrane-bound IgA1
18. Genetic variations in the CεmX domain of human membrane-bound IgE
19. Realizing potential: the state of Asian bioentrepreneurship
20. Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodies
21. Site-Specific Lipophilic Modification of Interferon-α
22. CϵmX peptide-carrying HBcAg virus-like particles induced antibodies that down-regulate mIgE-B lymphocytes
23. Anti-IgE as a mast cell–stabilizing therapeutic agent
24. Chapter 2 Cumulative Environmental Changes, Skewed Antigen Exposure, and the Increase of Allergy
25. Anti‐IgE Antibodies for the Treatment of IgE‐Mediated Allergic Diseases
26. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model
27. Antibodies to Hepatitis B Surface Antigen Potentiate the Response of Human T Lymphocyte Clones to the Same Antigen
28. Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: Tolerability and pharmacokinetics in cynomolgus monkeys,Macaca fascicularis
29. Preparing a human membrane and secreted protein-enriched cDNA library using PCR primers derived from a genomic database
30. Antigen-specific Immunoglobulin-A Prevents Increased Airway Responsiveness and Lung Eosinophilia after Airway Challenge in Sensitized Mice
31. Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitis
32. The Effect of Intravenous Administration of a Chimeric Anti-IgE Antibody on Serum IgE Levels in Atopic Subjects: Efficacy, Safety, and Pharmacokinetics
33. Functional Characterisation of HIV-1 gag-pol Fusion Protein
34. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120
35. Ontogeny of Human IgE-expressing B Cells and Plasma Cells
36. Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
37. A bispecific antibody binding to RANKL and osteonectin with enhanced localization to the bone
38. Bispecific Antibody Binding To RANKL and Osteonectin with Enhanced Localization to the Bone
39. Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
40. Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody
41. Preparation of human IgG1 monoclonal antibody specific for house dust mite allergens Der p 2 and Der f 2 by single B cell PCR of VH and VL segments (HYP7P.275)
42. Developing an antibody targeting CεmX of mIgE for the treatment of IgE-mediated diseases (HYP4P.305)
43. Monoclonal Antibodies in Clinical Investigations
44. RELEASE OF GLUCONEOGENIC PRECURSORS FROM SKELETAL MUSCLE
45. PRODUCTION OF MONOCLONAL ANTIBODIES BY HYBRIDOMA METHOD
46. MONOCLONAL ANTIBODIES: PREPARATION BY HYBRIDOMA METHOD AND APPLICATIONS IN BIOLOGICAL RESEARCH
47. Transgenic mice whose γ 1 and κ genes have been replaced by human ε and κ genes (HYP3P.402)
48. Developing an antibody targeting CεmX of mIgE for the treatment of allergic and other IgE-mediated diseases (VAC6P.954)
49. Two potential therapeutic antibodies bind to a peptide segment of membrane-bound IgE in different conformations
50. Structural analysis of epitopes recognized by two anti-CϵmX mAbs reveals intrinsic disorder of the CϵmX domain (P6002)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.